Written by Frank Schuler on . Posted in Science.

When it comes to medical cannabis, inhaled consumption methods can be seen as controversial within certain medical and political circles. After all, so much effort has been spent encouraging people to not smoke tobacco cigarettes, and many people see the two products as being one and the same. However, tobacco and cannabis are not the same thing, and studies demonstrate that.

Many lawmakers around the globe seem to be hesitant to legalize medical cannabis in forms that involve inhalation, which is unfortunate. For many suffering patients, inhaling cannabis is the cheapest and easiest way to consume their medicine, and given that inhaled cannabis interacts with the human body quicker compared to ingested cannabis, many patients prefer it for one reason or another.

Suffering patients should be able to consume cannabis in any manner that helps them, including inhaling it. A recent study from the United Kingdom found that inhaled cannabis may help treat pain and anxiety. Below is more information about it via a news release from NORML:

London, United Kingdom: The sustained vaporization of THC-dominant cannabis flowers improves health-related quality of life measurements in patients suffering from chronic pain and anxiety-related disorders, according to observational data published in the journal Biomedicines.

A team of British and Spanish investigators assessed cannabis’ efficacy in a cohort of 451 British patients authorized to consume cannabis flowers for treatment-resistant pain and/or anxiety. Patients in the study were all enrolled with Project Twenty21, “the first U.K. multi-center registry seeking to develop a body of real-world evidence to inform on the effectiveness and safety of medical cannabis.” All of the study’s participants had failed to respond to at least two prescription treatment options prior to obtaining an authorization for medical cannabis. All participants vaporized cannabis flowers for a period of at least three months.

Researchers reported that cannabis inhalation was associated with sustained (6+ months) improvements in both patient populations and that side effects were “minimal.” Investigators reported more significant improvements among those diagnosed with treatment-resistant anxiety.

“Our results indicate that controlled inhalation of pharmaceutical grade, THC-predominant cannabis flos [flowers] is associated with a significant improvement in patient-reported pain scores, mood, anxiety, sleep disturbances and overall HRQoL [health-related quality of life] in a treatment-resistant clinical population,” authors concluded.

Numerous surveys indicate that patients most frequently self-report using cannabis to mitigate symptoms of pain and anxiety.

Full text of the study, “Controlled inhalation of THC-predominant cannabis flos (flowers for inhalation) improves health-related quality of life and symptoms of pain and anxiety in eligible UK patients,” appears in Biomedicines.

United Kingdom



Photo: All Nations
Bryson, assistant grower from Shxwhá:y Village, learns the ropes to become a master grower at the All Nation Shxwhá:y Village cannabis cultivation facility.

Cannabis has been an economic driver for Indigenous communities across Canada.

It has also been part of some Indigenous cultures for many generations.

Indigenous owned and affiliated companies are helping with employment, entrepreneurship, and tourism, as well as helping contribute to the cultural conversation happening in Canada.

Here are five Indigenous-owned cannabis producers to check out and try:

Sugar Cane Cannabis

Sugar Cane Cannabis
Photo: Contributed




Located in Williams Lake, Sugar Cane is BC’s first farmgate craft cannabis cultivator.

Sugar Cane is wholly owned by Williams Lake First Nation (WLFN). Sugar Cane Cannabis was part of WLFN’s vision to produce the highest-quality, small-batch craft cannabis and to make it available to people directly from the facility in which it is grown.

Their journey started in 2020, when construction of a 7,000-square-foot purpose-built facility started. In 2022, construction was completed, and Sugar Cane Cannabis received its micro-cultivation licence. Sugar Cane features state-of-the-art cultivation techniques, an industry-leading grow team, and a spectacular boutique retail outlet offering a truly curated cannabis experience.

They’re located in Secwepemc Territory in Williams Lake, BC.

Sugar Cane Cannabis

Seven Leaf

Seven Leafs
Photo: Contributed




A room full of Wappa at Seven Leaf on Akwesasne Mohawk Territory in the province of Ontario.

Seven Leaf’s roots and heritage as an Indigenous licensed producer is apparent from the get-go, with the name SOVE7EIGN, referencing the importance of what it means to have sovereignty and independence as a First Nations community.

The Akwesasne Kanienʼkehá꞉ka (Mohawk) territory where they are based has a long-standing history of geographical complexity. The land straddles both international (U.S. and Canada) and provincial (Ontario and Québec) borders. The name SOVE7EIGN works in synergy with the branding, which features topographical renditions of the land shown as a single entity, as well as the exact coordinates for the reservation.

Seven Leaf

All Nations

All Nations Cannabis Products
Photo: BLKMKT85/thebccs




All Nations has been receiving rave reviews on Reddit.

All Nations is leading the way for meaningful Indigenous participation in the licensed cannabis industry.

They aspire to be the world’s largest Indigenous cannabis company delivering prosperity and social impact to the communities where live and work.

All Nations combines BC grown cannabis, expertise and Indigenous social impact to create a powerful cannabis presence which is becoming recognized as a high quality producers and unique business model that has unprecedented growth potential.

They’ve released Stó꞉lō Haze and Mac Daddy.

All Nations

Red Market Brand

Red Market

Photo: Contributed




Red Market products are available in Ontario.

Red Market Brand launched on June 21, 2021 — National Indigenous People’s Day.

Their logo is the symbol for ‘Prosperity’ in Anishinaabe tradition.

The company brings Canadians another way to support First Nations communities. The Red Market applies their collective knowledge and wisdom, combined with modern cannabis expertise, to cultivate and support Indigenous communities.

Through Red Market, founder and CEO Isadore Day believes that true Indigenous nationhood can be achieved by striving in every way for the development of healthy, wealthy Indigenous communities.

Red Market acknowledges and respects their roots by devoting a portion of their profits to creating sustainable First Nation community health and wealth.

Red Market

JBuds Cannabis

J Buds Cannabis Store
Photo: Contributed




JBuds is located in Summerland, BC.

Exceptional cannabis isn’t the only thing JBuds is working toward.

The family has a history of working on environmental cleanup projects in the Canadian North and works hard to ensure limits on the environmental impact of all activities that JBuds is involved with.

As an Indigenous-owned company they encourage a diverse working environment and have implemented training programs to encourage professional development for all staff.

A family owned and operated micro-cultivation facility in Summerland, brothers Noah and Dillion Johnson work together to lead the cultivation team. Having grown up together off the grid in the Northwest Territories, the brothers have a strong connection and they cultivate the crops with care and attention.

Harvests are hang dried and slow cured and  all stages including hanging, drying, trimming and storage happen in carefully controlled environments.



Where the oz. is located, in the Okanagan Valley of BC, we live and work within the unceded territory of the Syilx/Okanagan People.

psilocybin-assisted psychotherapy

Vancouver-based Numinus Wellness Inc. has announced a 30-person clinical trial to establish the best practices for treating substance use disorders with psilocybin-assisted psychotherapy.

According to a press release, the trial will be focused on treating tobacco, stimulant, alcohol and opioid disorders.

A 2017 study published in The American Journal of Drug and Alcohol Abuse found that psilocybin-assisted psychotherapy “holds considerable promise” for treating tobacco addiction. After 12 months of psilocybin therapy sessions, roughly 70 per cent of participants had abstained from smoking.

psilocybin trial test

Published: Nov. 1, 2022
By Becca Clarkson  – Reporter – 

A Vancouver-based pharmaceutical company will run the first take home psilocybin clinical trial in North America.

Health Canada has approved phase two of the trial by Apex Labs, which will evaluate the safety and efficacy of its low dose, multi-dose product APEX-52 in treating depression in veterans with post-traumatic stress disorder.

Veterans Affairs Canada estimates up to 10 per cent of war-zone veterans have been diagnosed with PTSD. That’s twice the amount of diagnoses the general adult population has received, according to Statistics Canada.

Apex Labs CEO Tyler Powell says many veterans are already self-medicating with micro-doses of unregulated psilocybin products

“Our goal is to expand access to pharmaceutical grade drug products through regulated systems, providing transparency and support for patients in need,” Tyler said in a statement released Tuesday.

The Oct. 24 approval comes nearly 11 months after Health Canada broadened the Special Access Program to include MDMA and psilocybin, a psychedelic compound found in “magic mushrooms” that research shows can have antidepressant effects.

This exemption means that health care professionals can use psilocybin on a case-to-case basis if they think a patient would benefit.

CBD helps cure boy who had 1000 epileptic seizures per month.

By: Amy Sharpe – News Reporter – The Mirror UK

Published: 31 Oct 2022 –

A boy who used to endure 500 life-threatening fits a month is set to celebrate his 1,000th seizure-free day, thanks to medical cannabis.

Alfie Dingley, who suffers from severe epilepsy, is one of just three people in the UK to have been handed an NHS prescription for the drug.

Mum Hannah Deacon says the cannabis – which was legalised for medicinal use on November 1, 2018 – has made a huge difference to the 11-year-old’s life.

Yet thousands of people are still unable to access funded prescriptions, with families forced to spend thousands of pounds a month to go private, or buy the drug illegally.

National Institute for Health and Care Excellence guidance allows ­clinicians to prescribe medical cannabis if the evidence suggests it could be beneficial.

But the British Paediatric and Neurology Association does not support the use of whole plant medicinal cannabis, which contains the psychoactive ingredient THC, claiming that the firms producing the products have not undertaken the required clinical trials to prove their safety.

Hannah, 43, who co-founded MedCan Support for families looking to access the drug, said this stance has created what she described as “a block” on NHS prescriptions.

She told how medical cannabis had given Alfie back his “quality of life”, allowing him to attend school full-time and start making friends.

But she said: “Some people have no choice but to spend £24,000 a year during a cost-of-living crisis just to keep their child safe.

 The CBD oil and THC oil used by Alfie Dingley
Alfie suffers from a rare form of epilepsy ( Image: Rowan Griffiths)

“We see families fundraising, which is demoralising, but others are going to the illegal market, where they don’t know what’s in the product and they are risking prosecution.

“As many as 1.8 million people use illegal cannabis for medical reasons. The Government has a responsibility to keep them safe.”

Alfie, who started having seizures when he was a baby and is also autistic, has a funded ­prescription for Bedrolite – a CBD oil that contains less than 1% THC and 7.5% CBD.

Alfie suffers from a rare form of epilepsy ( Image: Rowan Griffiths)

He made history in June 2018 when the Home Office gave his doctor the first licence to prescribe medical cannabis. Today, Alfie marks his 985th day without a seizure – and next month he will hit the milestone of 1,000. Hannah said: “Alfie is evidence it works… it is safe for him.

“It is not a miracle cure as he still has an epilepsy condition, but because the seizures are not happening, it has helped him sleep and engage.

“It has given him a quality of life. He’s reading – before, he couldn’t say more than two or three sentences – and he is learning and understanding normal relationships and asking questions. He has made friends and as a result, I have made friends.”